1988
DOI: 10.1016/0006-291x(88)90510-4
|View full text |Cite
|
Sign up to set email alerts
|

Two new hormones: Prohormone atrial natriuretic peptides 1–30 and 31–67 circulate in man

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
38
0

Year Published

1989
1989
2000
2000

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 105 publications
(40 citation statements)
references
References 13 publications
2
38
0
Order By: Relevance
“…Because this carboxy-terminal product was readily detectable and exhibited nearly all of the actions of atrial extracts, virtually all subsequent studies focused on the actions of ANP("-126). However, early studies also showed that intact ANP(-126) exhibits biological activity (5 (8,9). This circulating peptide coeluted with authentic synthetic ANP31-67 on reverse phase HPLC, and was shown by gel filtration to have a molecular mass of 4,000, similar to that of authentic ANP31-67 (9).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Because this carboxy-terminal product was readily detectable and exhibited nearly all of the actions of atrial extracts, virtually all subsequent studies focused on the actions of ANP("-126). However, early studies also showed that intact ANP(-126) exhibits biological activity (5 (8,9). This circulating peptide coeluted with authentic synthetic ANP31-67 on reverse phase HPLC, and was shown by gel filtration to have a molecular mass of 4,000, similar to that of authentic ANP31-67 (9).…”
Section: Discussionmentioning
confidence: 99%
“…They further demonstrated that, like ANPg9 126, this peptide circulates at increased concentrations after HOWL, and in patients with congestive heart failure (8-10). Importantly, this peptide achieves higher plasma levels and exhibits a longer half-life than ANP99-,26 (8)(9)(10) Little is known of the mechanism by which ANP(31-67) exerts its renal actions. Our results show that unlike ANP(99126), which inhibits Na+ entry through the amiloride-sensitive Na+ channel (14,15), ANP(31-7) is a potent inhibitor of This mechanism of action distinguishes ANP31-67 from ANP99-,26 because the binding ofthe latter to its receptor stimulates cGMP accumulation which in turn reduces Na' entry via the amiloride-sensitive cation channel (12,14,15,23,24).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Subjects with a creatinine level Ͼ1.5 mg/dL were excluded because vessel dilator increases in the circulation of humans with renal failure. 7,8 Likewise, vessel dilator increases in the circulation of persons with ascites, 9,10 so these subjects were excluded from the present study. None of the patients' prescribed medications were taken the day of the study.…”
Section: Chf Volunteersmentioning
confidence: 99%